Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Mavoglurant> ?p ?o. }
Showing items 1 to 45 of
45
with 100 items per page.
- Mavoglurant abstract "Mavoglurant (AFQ-056) is an experimental drug candidate for the treatment of fragile X syndrome. It exerts its effect as an antagonist of the metabotropic glutamate receptor 5 (mGLU5).Mavoglurant is under development by Novartis and is currently in Phase II and Phase III clinical trials. If successful, it would be the first drug to treat the underlying disorder instead of the symptoms of fragile X syndrome.Mavoglurant is also in Phase II clinical trials for Levodopa-induced dyskinesia.In 2007, Norvartis had conducted a clinical study to assess its ability of reducing cigarette smoking, but no results had been published up till now. Currently Novartis is conducting a clinical trial with this drug on Obsessive Compulsive Disorder.".
- Mavoglurant iupacName "Methyl (3aR,4S,7aR)-4-hydroxy-4-[(3-methylphenyl)ethynyl]octahydro-1H-indole-1-carboxylate".
- Mavoglurant thumbnail Mavoglurant.svg?width=300.
- Mavoglurant wikiPageID "34640421".
- Mavoglurant wikiPageRevisionID "600841165".
- Mavoglurant hasPhotoCollection Mavoglurant.
- Mavoglurant imagefile "Mavoglurant.svg".
- Mavoglurant imagesize "180".
- Mavoglurant iupacname "Methyl -4-hydroxy-4-[ethynyl]octahydro-1H-indole-1-carboxylate".
- Mavoglurant othernames "AFQ056".
- Mavoglurant subject Category:Alcohol.
- Mavoglurant subject Category:Alkynes.
- Mavoglurant subject Category:Carbamates.
- Mavoglurant subject Category:Methyl_esters.
- Mavoglurant type Abstraction100002137.
- Mavoglurant type Acetylene114600742.
- Mavoglurant type AliphaticCompound114601294.
- Mavoglurant type Alkynes.
- Mavoglurant type Carbamate114792281.
- Mavoglurant type Carbamates.
- Mavoglurant type Chemical114806838.
- Mavoglurant type Compound114818238.
- Mavoglurant type Ester114850483.
- Mavoglurant type Material114580897.
- Mavoglurant type Matter100020827.
- Mavoglurant type MethylEsters.
- Mavoglurant type OrganicCompound114727670.
- Mavoglurant type Part113809207.
- Mavoglurant type PhysicalEntity100001930.
- Mavoglurant type Relation100031921.
- Mavoglurant type Salt115010703.
- Mavoglurant type Substance100019613.
- Mavoglurant type ChemicalCompound.
- Mavoglurant type ChemicalSubstance.
- Mavoglurant type ChemicalObject.
- Mavoglurant type Thing.
- Mavoglurant comment "Mavoglurant (AFQ-056) is an experimental drug candidate for the treatment of fragile X syndrome. It exerts its effect as an antagonist of the metabotropic glutamate receptor 5 (mGLU5).Mavoglurant is under development by Novartis and is currently in Phase II and Phase III clinical trials.".
- Mavoglurant label "Mavoglurant".
- Mavoglurant sameAs m.0j251p7.
- Mavoglurant sameAs Q6589598.
- Mavoglurant sameAs Q6589598.
- Mavoglurant sameAs Mavoglurant.
- Mavoglurant wasDerivedFrom Mavoglurant?oldid=600841165.
- Mavoglurant depiction Mavoglurant.svg.
- Mavoglurant isPrimaryTopicOf Mavoglurant.